LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 70.40
-5.10 (-6.75%)
May 8, 2026, 1:30 PM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 5.68 billion as of May 8, 2026. Its market cap has increased by 266.67% in one year.
Market Cap
5.68B
Enterprise Value
5.19B
Revenue
243.15M
Ranking
n/a
PE Ratio
23.15
Stock Price
70.40
Market Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 5.68B, an increase of 229.48%. That is a compound annual growth rate of 5.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 5.68B | 116.95% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Handa Pharmaceuticals | 11.70B |
| Standard Chemical & Pharmaceutical | 10.92B |
| Alar Pharmaceuticals | 9.15B |
| Formosa Laboratories | 6.53B |
| Orient Pharma | 5.81B |
| SCI Pharmtech | 5.58B |
| Easywell Biomedicals | 4.49B |
| Orient EuroPharma | 4.04B |